Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.53% | 47.49% | 8.96% | 10.33% | 1.59% |
| Total Depreciation and Amortization | 34.76% | 24.24% | -4.35% | -2.82% | -1.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.21% | -10.45% | 56.21% | -63.10% | 43.39% |
| Change in Net Operating Assets | -1.43% | -310.29% | -50.13% | 758.12% | 68.12% |
| Cash from Operations | 28.45% | -186.78% | -75.64% | 76.10% | 33.85% |
| Capital Expenditure | 47.01% | -95.85% | -381.82% | 77.55% | -60.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 47.01% | -95.85% | -381.82% | 77.55% | -60.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | 20.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 19,775.51% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 0.00% | 112.77% | -- |
| Cash from Financing | 20,977.78% | 80.00% | 0.00% | -99.63% | 135,300.00% |
| Foreign Exchange rate Adjustments | 51.92% | 34.18% | -11,950.00% | -98.67% | 323.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 258.55% | -143.63% | -134.25% | -119.58% | 179.91% |